Consolidated Income Statement (IFRS) – (unaudited)

  Note   Three Months
Ended
09/30/2014 
Three Months
Ended
09/30/2013 
Nine Months
Ended
09/30/2014 
Nine Months
Ended
09/30/2013 
Continuing Operations:
Revenues 2 16,399,454 15,358,815 46,947,061 63,590,890
Operating Expenses 2
Research and Development   17,391,592 13,150,628 40,780,763 35,895,473
Selling, General and Administrative   3,603,090 4,822,698 10,349,500 13,246,828
Total Operating Expenses 20,994,682 17,973,326 51,130,263 49,142,301
Other Income   455,328 201,593 686,180 620,601
Other Expenses   9,460 269,963 240,328 421,165
Earnings before Interest and Taxes (EBIT) (4,149,360) (2,682,881) (3,737,350) 14,648,025
Finance Income   962,368 41,166 1,510,178 613,696
Finance Expenses   11,352 17,958 80,053 76,038
Income Tax Income / (Expenses)   626,631 565,937 299,160 (4,296,341)
Result from Continuing Operations (2,571,713) (2,093,736) (2,008,065) 10,889,342
Result from Discontinued Operations   0 (12,427) 0 5,971,812
Consolidated Net (Loss) / Profit (2,571,713) (2,106,163) (2,106,163) 16,861,154
Basic Net Profit / (Loss) per Share   (0,10) (0,08) (0,08) 0,69
thereof from Continuing Operations   (0,10) (0,08) (0,08) 0,45
thereof from Discontinued Operations   0,00 0,00 0,00 0,24
Diluted Net (Loss) / Profit per Share   (0,10) (0,08) (0,08) 0,68
thereof from Continuing Operations   (0,10) (0,08) (0,08) 0,44
thereof from Discontinued Operations   0,00 0,00 0,00 0,24
Shares Used in Computing Basic Net Result per Share   25,926,944 25,692,619 25,881,815 24,546,256
Shares Used in Computing Diluted Net Result per Share   26,262,421 26,113,148 26,202,586 24,815,427

See accompanying Notes

Top